Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line.

Breast Cancer Res · 2000 · PMC13916 · PMID 11056686

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantP <0.01actually significant

The AS-4 clone, which had the lowest levels of BRCA1 protein, showed a highly significant (16-fold; P <0.01) stimulation of growth between days 5 and 8 of estrogen induction (Figs 2b and 4 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.